These results suggest that CCL21/CCR7 contributes to the time-dependent proliferation of human NSCLC cells by upregulating cyclin A, cyclin B1, and CDK1 potentially via the ERK pathway. The gene discussed is CCNB1; the disease is non-small cell lung carcinoma.